01 1Raks Pharma
01 1RALOXIFENE HYDROCHLORIDE, USP
01 1India
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2017-09-14
Pay. Date : 2017-08-01
DMF Number : 31952
Submission : 2017-08-23
Status : Active
Type : II
20
Raks Pharma Pvt Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA and WHO-GMP.
One of their notable products is RALOXIFENE HYDROCHLORIDE, USP, with a corresponding US DMF Number 31952.
Remarkably, this DMF maintains an Active status since its submission on August 23, 2017, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of September 14, 2017, and payment made on August 01, 2017, indicating their dedication to facilitating drug approvals, Categorized as Type II
